49
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?

      review-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The lethality of infectious diseases has decreased due to the implementation of crucial sanitary procedures such as vaccination. However, the resurgence of pathogenic diseases in different parts of the world has revealed the importance of identifying novel, rapid, and concrete solutions for control and prevention. Edible vaccines pose an interesting alternative that could overcome some of the constraints of traditional vaccines. The term “edible vaccine” refers to the use of edible parts of a plant that has been genetically modified to produce specific components of a particular pathogen to generate protection against a disease. The aim of this review is to present and critically examine “edible vaccines” as an option for global immunization against pathogenic diseases and their outbreaks and to discuss the necessary steps for their production and control and the list of plants that may already be used as edible vaccines. Additionally, this review discusses the required standards and ethical regulations as well as the advantages and disadvantages associated with this powerful biotechnology tool.

          Related collections

          Most cited references155

          • Record: found
          • Abstract: found
          • Article: not found

          Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium.

          The transcytosis of antigens across the gut epithelium by microfold cells (M cells) is important for the induction of efficient immune responses to some mucosal antigens in Peyer's patches. Recently, substantial progress has been made in our understanding of the factors that influence the development and function of M cells. This review highlights these important advances, with particular emphasis on: the host genes which control the functional maturation of M cells; how this knowledge has led to the rapid advance in our understanding of M-cell biology in the steady state and during aging; molecules expressed on M cells which appear to be used as "immunosurveillance" receptors to sample pathogenic microorganisms in the gut; how certain pathogens appear to exploit M cells to infect the host; and finally how this knowledge has been used to specifically target antigens to M cells to attempt to improve the efficacy of mucosal vaccines.
            • Record: found
            • Abstract: found
            • Article: not found

            The production of recombinant pharmaceutical proteins in plants.

            Imagine a world in which any protein, either naturally occurring or designed by man, could be produced safely, inexpensively and in almost unlimited quantities using only simple nutrients, water and sunlight. This could one day become reality as we learn to harness the power of plants for the production of recombinant proteins on an agricultural scale. Molecular farming in plants has already proven to be a successful way of producing a range of technical proteins. The first plant-derived recombinant pharmaceutical proteins are now approaching commercial approval, and many more are expected to follow.
              • Record: found
              • Abstract: found
              • Article: not found

              Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming.

              Dendritic cells (DC) are key regulators of both protective immune responses and tolerance to self-antigens. Soon after their discovery in lymphoid tissues by Steinman and Cohn, as cells with the unique ability to prime naïve antigen-specific T cells, it was realized that DC can exist in at least two distinctive states characterized by morphological, phenotypic and functional changes-this led to the description of DC maturation. It is now well appreciated that there are several subsets of DC in both lymphoid and non-lymphoid tissues of mammals, and these cells show remarkable functional specialization and specificity in their roles in tolerance and immunity. This review will focus on the specific characteristics of DC subsets and how their functional specialization may be regulated by distinctive gene expression programs and signaling responses in both steady-state and in the context of inflammation. In particular, we will highlight the common and distinctive genes and signaling pathways that are associated with the functional maturation of DC subsets. © 2014 The Authors.

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Vaccines (Basel)
                Vaccines (Basel)
                vaccines
                Vaccines
                MDPI
                2076-393X
                30 May 2017
                June 2017
                : 5
                : 2
                : 14
                Affiliations
                [1 ]Departamento de Biología Marina, Universidad Católica del Norte, Programa de Doctorado en Biología y Ecología Aplicada, Coquimbo 1780000, Chile; christopher.concha@ 123456ucn.cl
                [2 ]Departamento de Ingeniería en Alimentos, Universidad de La Serena, Programa de Doctorado en Ingeniería en Alimentos y Bioprocesos, La Serena 1700000, Chile; raulhcs@ 123456gmail.com (R.C.); mtorresossandon@ 123456gmail.com (M.J.T.)
                [3 ]Departamento de Biología, Universidad de La Serena, Programa de Doctorado en Ingeniería en Alimentos y Bioprocesos, La Serena 1700000, Chile; johanmacuer@ 123456gmail.com
                [4 ]Facultad de Salud, Universidad Autónoma de Chile, Talca 3460000, Chile; andresherradah@ 123456gmail.com
                [5 ]Departamento de Química, Universidad de La Serena, La Serena 1700000, Chile; fjamett@ 123456userena.cl
                [6 ]Departamento de Biología, Universidad de La Serena, La Serena 1700000, Chile
                Author notes
                [* ]Correspondence: cibanez@ 123456userena.cl ; Tel.: +56-51-2204309; Fax: +56-51-2204383
                Article
                vaccines-05-00014
                10.3390/vaccines5020014
                5492011
                28556800
                6867ffbf-4022-4e79-88b9-11c0bfbd4594
                © 2017 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 17 February 2017
                : 23 May 2017
                Categories
                Review

                edible vaccine,medicinal food,genetic modification,immunogenicity,disease outbreaks,food biotechnology

                Comments

                Comment on this article

                Related Documents Log